OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
June 02, 2022
When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.
This article explores the concerns with cleaning pharmaceutical products utilizing LNP delivery vehicles and provides a general cleaning recommendation based on laboratory and field testing.
The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.
EMA has been assigned a formal role in preparing for and managing future public health crises within the EU through the formalization of ad-hoc structures and processes that were employed during the COVID-19 pandemic.
Cases of monkeypox are rising around the world, but it is unlikely the virus will become a pandemic problem.
FDA will use virtual site visits even after resuming active inspections.
Is AI a panacea for pharma’s productivity gap?
Precompetitive consortiums seek solutions to industry-wide challenges.
Lions and tigers and monkeypox, oh my!
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the basics for maintaining an acceptable working relationship between a client and their CDMO.